Giuseppe Toffoli is the Director of the Clinical and Pharmacological Department of the National Cancer Institute in Aviano, Italy. He leads the coordination activities in the fields of pharmacological research and nanomedicine, clinical care and teaching with the aim of developing new drugs and therapies. This work is carried out in close collaboration with the operational units of the Aviano and local, national, and international multidisciplinary groups. He manages activities in the "regulatory" field as a member of the Technical and Scientific Committee of the Italian Medicines Agency (AIFA), appointed by the Minister, a member of the Board of Directors of the Istituto Superiore di Sanità, Italy, a member of the Regional Appeals Board of the University Hospital "S. Maria della Misericordia" "of Udine, appointed by the Region, and a member of ethics committees. He coordinates the activities of projects won in competitive calls (i.e., AIRC 5 per mille special programs, targeted research, etc.) involving 15 Italian research groups with the participation of 114 researchers (university professors, SOC directors, contractors, and fellows). He participates as Head of Unit in Horizon 2020 European projects involving 10 European countries. The teaching and training activities are mainly carried out in the pharmacological field. He coordinated the activities of regional projects (FOIFVG) aimed at the prescriptive appropriateness of drugs and the optimization of resources.